Chemoradiation for muscle-invasive bladder cancer using 5-fluorouracil versus capecitabine: A nationwide cohort study-Reference-Cited by-同舟云学术

Chemoradiation for muscle-invasive bladder cancer using 5-fluorouracil versus capecitabine: A nationwide cohort study

Published:2023-06 Issue: Volume:183 Page:109584
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

de Haar-Holleman Amy,van Hoogstraten Lisa M.C.,Hulshof Maarten C.C.M.,Tascilar Metin,Brück Katharina,Meijer Richard P.,Alfred Witjes J.,Kiemeney Lambertus A.,Aben Katja K.H.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference28 articles.

1. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review;Ploussard;Eur Urol,2014

2. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an International collaborative multistakeholder effort(†): under the auspices of the EAU-ESMO guidelines committees;Witjes;Eur Urol,2020

3. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233;Mak;J Clin Oncol,2014

4. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer;James;N Engl J Med,2012

5. Chemoradiotherapy in muscle-invasive bladder cancer: 10-yr follow-up of the phase 3 randomised controlled BC2001 trial;Hall;Eur Urol,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy;Strahlentherapie und Onkologie;2024-09-04

2. Immunotherapy and radiotherapy for older patients with invasive bladder cancer unfit for surgery or chemotherapy: practical proposal by the international geriatric radiotherapy group;Frontiers in Oncology;2024-07-04

3. Unveiling FDA-Approved Drugs and Formulations in the Management of Bladder Cancer: A Review;Current Pharmaceutical Biotechnology;2024-05-23

4. Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial;Frontiers in Oncology;2023-08-29